Azura Ophthalmics announced it has received positive feedback from a pre-New Drug Application (NDA) meeting with the US Food ...

Praxis Precision Medicines, Inc. soars after study success and pipeline wins. Explore key milestones, projections, and ...

Cogent Biosciences (COGT) shares have surged after pivotal bezuclastinib data in imatinib-resistant aGIST. Read the latest ...

Praxis Precision Medicines has also announced a “successful” pre-NDA meeting with the FDA for its essential tremor drug ...

Shanghai Junshi Biosciences Co., Ltd (Junshi Biosciences, HKEX: 1877; SSE: 688180), a leading innovation-driven ...

Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system (CNS) disorders ...

Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT: 31R), a specialty life sciences company focused on the research and ...

A mobile brain scanning system, thought to be the first of its kind, is being developed to measure the effect of blast ...

In a separate announcement, Praxis revealed it successfully completed a pre-NDA meeting with the FDA regarding ulixacaltamide, its treatment for essential tremor. The company has gained alignment from ...

Revive Therapeutics (RVVTF) announced an update on its ongoing research study evaluating Bucillamine as a potential treatment for nerve agent ...

Amazon is considering some type of project in the SouthPointe Enterprise Campus, but city officials say it's not a data ...

Praxis Precision Medicine said it had completed its pre-new drug application meeting with the Food and Drug Administration for its essential tremor treatment. The company said Thursday it expects to ...